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Letters to the EditorThe extrapolation is based on Castro and
colleagues’ observation11 of a single death
among 114 patients (70% confidence limits
0.1%-3.0% mortality) in the concurrent set-
ting of 543 patients deemed not in need of
aortic root enlargement; the latter sustained
a mortality of 4.1% with 70% confidence
limits of 3.2% to 5.1%.11 These confidence
limits and the context caution against con-
cluding that widespread application of the
proposed algorithm is likely to lower oper-
ative mortality.
Small sets of data pose two dangers,
identifying spurious relations in small sub-
groups and failing to identify relations be-
cause of lack of statistical power. These
concerns motivated collaborators in the
multi-institutional study to contribute more
than 13,000 patients with 70,000 patient
years of follow-up.
Disclaimer
In responding to this letter, we must ac-
knowledge that we reside within the insti-
tution with the highest volume of heart
valve operations on the North American
continent. The practice at The Cleveland
Clinic Foundation has not been to avoid
using small-sized prostheses in small aortic
roots. Yet hospital mortality for 881 pri-
mary isolated aortic valve replacements in
the last 5 years was 1.2%, and for 996
primary combined aortic valve replace-
ments with coronary artery bypass grafting
it was 2.0%. In some instances, left ven-
tricular outflow tract myectomy is per-
formed for obstruction at that level, but
rarely is aortic root enlargement per-
formed.
We remain interested in performance of
prostheses, but we believe that available
evidence suggests that other factors have
more impact on long-term all-cause mor-
tality than does prosthesis-patient size,
however expressed.
Eugene H. Blackstone, MD
A. Marc Gillinov, MD
Delos M. Cosgrove, MD
Department of Thoracic and Cardiovascular
Surgery
The Cleveland Clinic Foundation
Cleveland, OH 44195
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Epidemiologic contrast of predictors’
trends for outcomes of coronary
artery bypass grafting: Heart failure
versus ventricular function versus
left main disease
To the Editor:
I read with interest the article by Davier-
wala and colleagues1 in the November
2003 issue of the Journal. The work ana-
lyzed differential change in predictors of in
hospital mortality after coronary artery by-
pass grafting. The study elegantly demon-
strated the diminishing statistical signifi-
cance for left ventricular function greater
than 20% as a predictor for mortality dur-
ing a 12-year period. Several explanations
are provided related to patient comorbidity,
interventional cardiology, surgeon experi-
ence, and intensive patient care. It is well
ascular Surgery ● June 2004established that one of the major determi-
nants of morbidity during and after coro-
nary artery bypass grafting is low left ven-
tricular ejection fraction.2 The results of
numerous coronary artery bypass grafting
trials performed in the 1970s and 1980s
show that despite this increased morbidity,
the benefits of this procedure for patients
with multivessel coronary artery disease
and low left ventricular systolic function in
many cases outweigh the risks.3 The article
does not contain data for the actual causes
of death in this large group of patients,
which would be epidemiologically rele-
vant. Given the data provided, however, it
is difficult to observe a contrast in the
trends between congestive heart failure
(CHF) and left ventricular function as pre-
dictor variables. Davierwala and col-
leagues1 also stated in their discussion that
from studying the data again in Table 1 it is
clear to the reader that CHF held an in-
creasing proportion as morbidity in the pa-
tient cohort (7.8% vs 9.4% vs 9.4%) during
the interval (1990-1993 vs 1994-1997 vs
1998-2001). Moreover, according to the
original article’s Table 3, after a multivar-
iate analysis CHF showed an increasing
trend for odds ratio by year group (1.9 vs
3.6).1 Given this contrast of predictor out-
come trends, the authors should have in-
cluded other explanations. In simple terms,
the CHF increasing trend could reflect an
increase in diastolic heart failure, assuming
that the proportions of new patients in each
time interval were significant. In other
words, the decline of the predictor value in
left ventricular dysfunction was not related
to interyear group patient death. The au-
thors stated that left main disease in a
“somewhat counterintuitive finding” was
“unmasked” in the last time cohort, with an
odds ratio of 1.7 in Table 3 of the original
article.1 From their data, both CHF and left
main disease increased in prevalence, yet
worsening ventricular dysfunction de-
clined. This constellation may reflect a
change in the ventricular dysfunction func-
tion from systolic to diastolic biometri-
cally.
Furthermore, the typical risk factors and
comorbidities of female gender, diabetes,
and hypertension together increased signif-
icantly during the entire period of their
study. This association has now been found
to be the same with diastolic dysfunction.4
As we know now, there is growing appre-
ciation of diastolic heart failure as a distinct
Letters to the Editorentity. There are 4.6 million people in the
United States with heart failure today, and
550,000 new cases are being reported an-
nually by the American Heart Associa-
tion.5 Approximately 30% to 50% of pa-
tients with heart failure have a normal or
nearly normal left ventricular ejection frac-
tion.6 CHF is a leading cause of cardiac
morbidity and mortality from cardiovascu-
lar disease. Although left ventricular dia-
stolic dysfunction occurs in all patients
with systolic dysfunction and CHF, a third
of patients have CHF with isolated dia-
stolic dysfunction. In the general popula-
tion, the mortality among patients with di-
astolic heart failure is 4 times that among
persons without heart failure but half that
among patients with systolic heart failure.
It is widely known that many physicians
underappreciate diastolic function in heart
failure.
Reinterpreting the data in the context of
the discussion asks for other explanations.
In the present era of advancements in echo-
cardiography, diastolic dysfunction needs
to be taken into consideration, especially
when symptoms of congestive heart failure
are present. If that is the case in this study,
left ventricular dysfunction remains a pre-
dictor of outcome but with a change from
systolic to diastolic. Finally, I ask Davier-
wala and colleagues to take a second look
at their data in the light of this forgotten
predictor variable. I would appreciate their
feedback.
Jeffrey H. Shuhaiber, MD
University of Illinois at Chicago
Chicago, IL 60612
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Reply to the Editor:
Dr Shuhaiber correctly points out that left
ventricular (LV) diastolic dysfunction is
frequently superimposed on either normal
or reduced systolic function in patients un-
dergoing coronary artery bypass grafting.
The importance of diastolic dysfunction in
the development and progression of con-
gestive heart failure (CHF) has been illus-
trated previously1 and is highlighted by the
divergent trends in the prevalence of LV
systolic dysfunction and CHF in the series
on which we reported. Early echocardio-
graphic signs of impaired LV relaxation
include decreased early transmitral LV fill-
ing and greater dependence on atrial con-
traction.2 Pseudonormalization of LV fill-
ing is observed as LV stiffness and left
atrial pressures continue to increase, and
finally severe diastolic dysfunction is
marked by rapid early filling, extreme LV
stiffness, and elevated diastolic pressures.
This diastolic dysfunction has been shown
to predict outcomes in patients with CHF
independently of systolic function.3
Despite this, echocardiographic charac-
terization and quantitation of LV diastolic
dysfunction is not performed and recorded
for all patients undergoing coronary sur-
gery. This may be due in part to logistical
issues and in part to underappreciation of
its prognostic significance. Like systolic
function, diastolic function may also vary
significantly with time in patients with in-
termittent ischemia or a maturing myocar-
dial infarction.
Our institutional database, initiated in
1982 and now encompassing approxi-
mately 40,000 surgical patients, does not as
yet contain uniform data on diastolic func-
tion, nor does the much larger Society of
Thoracic Surgeons database. Thus, al-
though one may reasonably speculate that
the prevalence of diastolic dysfunction in
patients undergoing coronary artery bypass
grafting is increasing in parallel with other
risk factors, as we have reported in this
series, our data do not currently permit
evaluation of the independent effect of di-
astolic function on mortality and morbid-
ity. These measures of diastolic dysfunc-
e Journal of Thoracic and Cardiovascular Stion will have to obtained routinely for all
patients undergoing surgery and incorpo-
rated into institutional and regional data-
bases before we be able to determine
whether the decreasing influence of LV
systolic dysfunction on outcomes has un-
masked relatively more subtle predictors,
including CHF and left main stenosis as we
have reported or diastolic dysfunction as
Dr Shuhaiber suggests.
Piroze M. Davierwala, MD
Terrence M. Yau, MD, MSc
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Extracapsular lymph node
involvement in esophageal cancer
and number of involved nodes
To the Editor:
We thank Dr DeMeester1 for his valuable
comments on our article “Extracapsular
Lymph Node Involvement Is a Negative
Prognostic Factor in T3 Adenocarcinoma
of the Distal Esophagus and Gastroesoph-
ageal Junction.”2 We fully agree with Dr
DeMeester1 that the number and character-
istics of lymph nodes are very important
determinants of survival in esophageal can-
cer, and we endorse his plea for taking the
number of involved nodes into account in
the TNM staging system of esophageal
cancer.
In his editorial,1 Dr DeMeester made
some points that we would like to clarify.
With regard to the survival in patients with-
out nodal involvement versus patients with
intracapsular nodal involvement, there was
no significant difference in survival. This
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